| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,871,900 | 1,731,600 | 1,580,400 | | Cost of Revenue | 425,000 | 394,400 | 370,300 | | | Gross Profit | 1,446,900 | 1,337,200 | 1,210,100 | | | Operating Expenses | | Research Development | 222,000 | 209,400 | 210,700 | | Selling General and Administrative | 739,200 | 736,800 | 720,900 | | Non Recurring | 83,800 | 18,700 | 44,600 | | Others | 34,100 | 14,800 | 26,600 | | | | Total Operating Expenses | 1,079,100 | 979,700 | 1,002,800 | | | | Operating Income or Loss | 367,800 | 357,500 | 207,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,100 | 78,000 | 94,800 | | Earnings Before Interest And Taxes | 380,900 | 435,500 | 302,100 | | Interest Expense | 17,000 | 1,100 | 1,500 | | Income Before Tax | 363,900 | 434,400 | 300,600 | | Income Tax Expense | 125,800 | 120,800 | 84,700 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 238,100 | 313,600 | 215,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 238,100 | 313,600 | 215,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $238,100 | $313,600 | $215,900 |
|
1.48% Nasdaq 
Income Statement
